首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Structure based molecular design, synthesis and biological evaluation of α-pyrone analogs as anti-HSV agent
【24h】

Structure based molecular design, synthesis and biological evaluation of α-pyrone analogs as anti-HSV agent

机译:基于结构的分子设计,α-吡喃酮类似物作为抗HSV药物的合成和生物学评估

获取原文
获取原文并翻译 | 示例
           

摘要

Several options for treating Herpes Simplex Virus type 1 and type 2 are available. However, non-specific inhibition and drug resistance warrants the discovery of new anti-herpetic compounds with better therapeutic profile or different mode of action. The non-nucleoside inhibitors of HSV DNA polymerase target the site that is less important for the binding of a natural nucleoside or nucleoside inhibitors. In the present study, we have explored the possibility to find a new lead molecule based on α-pyrone analogs as non-nucleoside inhibitors using structure based modeling approach. The designed molecules were synthesized and evaluated for anti-HSV activity using MTT assay. The compound 5h with EC 50 7.4 μg/ml and CC 50 52.5 μg/ml was moderately active against HSV when compared to acyclovir. A plaque reduction assay was also carried out and results reveal that 5h is more effective against HSV-1 with better selective index of 12.8 than against HSV-2 (SI = 3.6). The synthesized compounds were also evaluated for anti-HIV activity, but none were active.
机译:有几种治疗1型和2型单纯疱疹病毒的方法。然而,非特异性抑制和抗药性保证了发现具有更好治疗特性或不同作用方式的新型抗疱疹性化合物。 HSV DNA聚合酶的非核苷抑制剂靶向的位点对于天然核苷或核苷抑制剂的结合而言不太重要。在本研究中,我们已经探索了使用基于结构的建模方法,基于α-吡喃酮类似物作为非核苷抑制剂寻找新的先导分子的可能性。合成设计的分子,并使用MTT分析评估抗HSV活性。与无环鸟苷相比,EC 50 7.4μg/ ml和CC 50 52.5μg/ ml的化合物5h对HSV具有中等活性。还进行了噬斑减少试验,结果表明5小时对HSV-1更有效,选择性指数为12.8,比对HSV-2更好(SI = 3.6)。还评估了合成的化合物的抗HIV活性,但没有一个具有活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号